• Company

  • Technology Platform

  • Products

  • Services

  • Resources

  • News & Events

  • Contact Us

    • Inquiries
    • Careers
    • Distributors
  • More

    Use tab to navigate through the menu items.
    Quick Selection.png

    News

    August 17, 2021

    NeuCyte and KIF1A.ORG Enter Collaboration Agreement 

    January 19, 2021

    NeuCyte and Mount Sinai Enter Collaboration Agreement 

    September 25, 2019  

    NeuCyte and REPROCELL enter distribution agreement in North America and Europe

    September 24, 2019  

    NeuCyte licenses promising novel compound for treatment of refractory epilepsy and related neurological disorders

    December 3, 2018 

    NeuCyte outlicenses its novel neuronal programming technology 

    May 8, 2018

    NeuCyte completes Series A financing

    Events

    March 27-30, 2022

    NeuCyte exhibits and presents at Society of Toxicology annual meeting in San Diego, CA

    September 16-18,2020

    NeuCyte presents at Discovery on Target virtual conference

    September 14-17, 2020

    NeuCyte presents at Safety Pharmacology Society virtual meeting

    August 27-28, 2020

    NeuCyte presents at the Epilepsy Pipeline Conference virtual meeting

    Sept. 29 - Oct. 3, 2019 

    NeuCyte presents at the International Neurotoxicity Association Meeting in Düsseldorf, Germany

    September 23-26, 2019 

    NeuCyte exhibits at the Safety Pharmacology Society Annual Meeting

    July 24-26, 2019 

    NeuCyte presents at the Precision Medicine Ion Channel Retreat

    June 17-20, 2019

    NeuCyte exhibits and presents at the World Preclinical in Boston, MA

    March 10-14, 2019

    NeuCyte exhibits and presents at the SOT (Society of Toxicology) Annual Meeting

    319 N. Bernardo Avenue, Mountain View, CA 94043

    650-274-8199

    inquiries@neucytelabs.com

    • Grey LinkedIn Icon
    • Grey Twitter Icon
    NEUCYTE-FINAL LOGO.png

    Visit

    ©2022 BY NEUCYTE, INC